Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach

Recent data indicate that Tau immunotherapy may be relevant for interfering with neurofibrillary degeneration in Alzheimer disease and related disorders referred to as Tauopathies. The key question for immunotherapy is the choice of the epitope to target. Abnormal phosphorylation is a well-described...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Troquier, Laëticia, Caillierez, Raphaëlle, Burnouf, Sylvie, Fernandez-Gomez, Francisco J., Grosjean, Marie-Eve, Zommer, Nadège, Sergeant, Nicolas, Schraen-Maschke, Susanna, Blum, David, Buee, Luc
Format: Artigo
Sprache:Inglês
Veröffentlicht: Bentham Science Publishers 2012
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637173/
https://ncbi.nlm.nih.gov/pubmed/22272619
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge